PhD Student in Super-Resolution Microscopy and Glycobiology | PhD Student for super-resolution microscopy-based investigations of the glycocalyx (m/f/d)

Universitätsklinikum Erlangen AöR

Erlangen, Bayern, Deutschland
Published Mar 13, 2026
Part-time
No information

Job Summary

This PhD position offers a unique opportunity to conduct cutting-edge research at the intersection of optics, biology, and medicine within the EU-funded 'GLYCOCALYX' consortium. Based at the University Clinic Erlangen and the Max Planck Institute for the Science of Light, the successful candidate will perform spatial fingerprinting of nanoscale glycocalyx architecture. Day-to-day responsibilities include applying and developing integrated optical and biochemical frameworks, utilizing advanced microscopy techniques like DNA-PAINT and dSTORM, and collaborating with a transdisciplinary team of scientists. The role is highly collaborative, featuring secondments to other international labs in both academic and industrial settings. This position is particularly attractive for researchers seeking a world-class environment to study cellular processes at the nanometer scale while benefiting from the structured support of a European Doctoral Network and the stability of a German public service collective agreement (TV-L).

Required Skills

Education

Master’s degree in Biology, Biochemistry, Biophysics, or a related field.

Experience

  • Professional experience in advanced imaging, glycobiology, or biophysics
  • Experience in localization microscopy including setup alignment and data analysis
  • Experience in cell and molecular biology techniques such as cell culture and transfection
  • Experience in programming for simulations and data analysis
  • Experience in developing and optimizing labeling protocols

Languages

Not specified

Additional

  • Must meet MSCA mobility rule: cannot have lived or worked in Germany for more than 12 months in the 3 years prior to the start date. Position is part-time (30 h/week) for a duration of 3 years starting in 2026.